Key clinical point: A higher number of comorbidities was associated with lower quality of life.
Major finding: All comorbidities accounted for 18.09% of the variance of overall health-related quality of life.
Study details: A longitudinal study of 902 patients with MS.
Disclosures: This study was supported by Multiple Sclerosis Research Australia.
Lo LMP et al. ACTRIMS Forum 2019, Abstract 80.